CUV clinuvel pharmaceuticals limited

Revenue EXPLOSION Coming?, page-2

  1. 402 Posts.
    lightbulb Created with Sketch. 91
    Indeed, CUV's plan, although we sometimes bemoan and complain, does seem to be coming together very nicely in terms of revenue and profit. I REALLY want to buy more with the potential for the latest indications, but until I hear what the EMA say about the sixth indication, I'm actually afraid that, should it be negative, the historical shorting and manipulation could easily bring the SP to below $20 again. Having said that, with the historical safety data that CUV have produced upon which Scenesse has been approved as you say, I can't really see that they would spend time, effort and money on the sixth indication if they didn't believe that it would actually be efficacious to some degree.

    In anticipation of a fruitful meeting with the EMA..........

    GLA
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$11.25
Change
0.110(0.99%)
Mkt cap ! $563.8M
Open High Low Value Volume
$11.15 $11.36 $11.15 $1.189M 105.7K

Buyers (Bids)

No. Vol. Price($)
1 8646 $11.23
 

Sellers (Offers)

Price($) Vol. No.
$11.25 2541 1
View Market Depth
Last trade - 16.10pm 18/07/2025 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.